Lucira Health (LHDX) IPO Opens 30% Higher

Today's IPO for Lucira Health, Inc. (NASDAQ: LHDX) opened for trading at $22.10 after pricing 9,000,000 shares of common stock at a price to the public of $17.00 per share

BofA Securities and William Blair are acting as lead bookrunning managers and LifeSci Capital is acting as co-manager for the offering.

Lucira Health is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. Lucira has developed a testing platform that produces centralized-laboratory-accurate molecular testing in a single-use and consumer-friendly test kit that is powered by two AA batteries and fits in the palm of a hand. Lucira designed its test kits to provide accurate, reliable and on-the-spot molecular test results anywhere and at any time. The LUCIRA COVID-19 All-In-One Test Kit is designed to provide a clinically relevant COVID-19 result within 30 minutes from sample collection.

You May Also Be Interested In

• Rubrik IPO: 5 key things to know
• Games Global (GGL) Files for Proposed IPO
• Loar Holdings (LOAR) Announces 11M Share IPO at $24-$26/sh